Skip to content
clinical trials latin america
  • Careers
  • Sites and Network
Menu
  • Careers
  • Sites and Network
  • Español
Linkedin Twitter Facebook-f Youtube
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Insights
    • Careers
    • Our Science
    • News
  • Contact
Menu
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Insights
    • Careers
    • Our Science
    • News
  • Contact
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About Cohortias
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Insights
    • Careers
    • News
    • Our Science
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Contact
  • Ir a sitio en español
Menu
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About Cohortias
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Insights
    • Careers
    • News
    • Our Science
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Contact
  • Ir a sitio en español

Author: quickappsmkt

This author has written 373 articles
  1. Home>
  2. quickappsmkt>
  3. Page 3
Read more about the article Clinical Trial – Becker muscular dystrophy study.
Becker muscular dystrophy study

Clinical Trial – Becker muscular dystrophy study.

  • Post author:quickappsmkt
  • Post published:June 21, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

EDG-5506 was found to be well-tolerated without any serious adverse events reported.

Continue ReadingClinical Trial – Becker muscular dystrophy study.
Read more about the article Clinical Trial – New angiotensin II type 2 receptor agonist.
angiotensin

Clinical Trial – New angiotensin II type 2 receptor agonist.

  • Post author:quickappsmkt
  • Post published:June 20, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The drug is available orally with target engagement and anti-fibrotic effects in human fibrotic lung and kidney tissue.

Continue ReadingClinical Trial – New angiotensin II type 2 receptor agonist.
Read more about the article Clinical Trial – Traumatic brain injury therapy.
therapy

Clinical Trial – Traumatic brain injury therapy.

  • Post author:quickappsmkt
  • Post published:June 16, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial will evaluate multiple dose levels of AST-004 over six months at a clinical research site in Kistarcsa, Hungary.

Continue ReadingClinical Trial – Traumatic brain injury therapy.
Read more about the article Clinical Trial – Phase II data of achondroplasia trial.
achondroplasia

Clinical Trial – Phase II data of achondroplasia trial.

  • Post author:quickappsmkt
  • Post published:June 14, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Voxzogo improved height Z-score by 0.30 SD and annualised growth velocity by 0.92cm/year versus placebo.

Continue ReadingClinical Trial – Phase II data of achondroplasia trial.
Read more about the article Clinical Trial – B-cell lymphoma new therapy trial.
B-cell lymphoma

Clinical Trial – B-cell lymphoma new therapy trial.

  • Post author:quickappsmkt
  • Post published:June 13, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial subjects had an overall response rate and complete response rate of 63% and 39%, respectively.

Continue ReadingClinical Trial – B-cell lymphoma new therapy trial.
Read more about the article Clinical Trials – Data of adenoid cystic carcinoma therapy.
carcinoma

Clinical Trials – Data of adenoid cystic carcinoma therapy.

  • Post author:quickappsmkt
  • Post published:June 8, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial will evaluate rivoceranib in 80 patients, including 53 based in the US.

Continue ReadingClinical Trials – Data of adenoid cystic carcinoma therapy.
Read more about the article Cohortias – Healthcare market in Brazil.
Healthcare

Cohortias – Healthcare market in Brazil.

  • Post author:quickappsmkt
  • Post published:June 6, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

This is a best prospect industry sector for this country. Includes a market overview and trade data.

Continue ReadingCohortias – Healthcare market in Brazil.
Read more about the article Cohortias – Clinical Trial Monitoring.
Monitoring

Cohortias – Clinical Trial Monitoring.

  • Post author:quickappsmkt
  • Post published:June 1, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The responsibility of the clinical trial monitor is to ensure that the trial is being conducted in accordance with ICH GCP guidelines.

Continue ReadingCohortias – Clinical Trial Monitoring.
Read more about the article Cohortias – The research landscape of Latin America.
latin america

Cohortias – The research landscape of Latin America.

  • Post author:quickappsmkt
  • Post published:May 30, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Analysts at the Institute for Scientific Information report on the research profiles of 34 countries in South and Central America, Mexico and the Caribbean.

Continue ReadingCohortias – The research landscape of Latin America.
Read more about the article Clinical Trial – Phase 1b/3 breast cancer therapy trial.
breast cancer

Clinical Trial – Phase 1b/3 breast cancer therapy trial.

  • Post author:quickappsmkt
  • Post published:May 27, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial will analyze the safety and efficacy of afuresertib plus fulvestrant combination in HR+/HER2- breast cancer patients.

Continue ReadingClinical Trial – Phase 1b/3 breast cancer therapy trial.
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 38
  • Go to the next page

Direct Contact

[email protected]
covid clinical trials
  • [email protected]
  • +52 81 2719 3064
  • C. Del Comercio 565, SPGG, N.L. México.
  • Privacy Policy

Solutions

  • Full Service CRO
  • Research & Development
  • Study Design
  • Sites Activation
  • Protocol Writing

Company

  • Cohortias Core
  • Background
  • Locations
  • Team Members
  • Opportunities

get started

  • Know Latin America
  • Standard-of-care
  • Regulatory Infrastructure
  • Cases & Evidence
  • Resources

Quarterly Newsletter

Cohortias International © All rights reserved

Linkedin Twitter Facebook-f Youtube